Latest News in the pharma Industry
Research & Development
Lilly's Taltz shows promise for patients with active psoriatic arthritis
15 Jun 2017
Demonstrated significant improvements in disease signs and symptoms at 24 weeks among patients with active psoriatic arthritis who had prior inadequate response or intolerance to TNF inhibitors.
Read more
LifeArc, previously MRC Technology, set to transform the medical research landscape
15 Jun 2017
Investment will focus on new innovations in therapeutics for neurodegeneration, antibiotic resistance, cancer and respiratory diseases.
Read more
Irvine Scientific adds new Center of Excellence for R&D
14 Jun 2017
Company adds fifth building in Southern California.
Read more
Successful Phase III top-line results with Bekinda for acute gastroenteritis
14 Jun 2017
Study successfully met its primary endpoint and Bekinda 24 mg was shown to be effective, safe and well tolerated in patients with acute gastroenteritis and gastritis.
Read more
Achelios Therapeutics concludes successful Type C meeting with FDA regarding Topofen
14 Jun 2017
Currently there are no approved topical NSAIDs indicated for the treatment of migraine.
Read more
Lilly's galcanezumab significantly reduces number of migraine headache days
12 Jun 2017
New results presented at AHS.
Read more
Lilly announces strategic collaboration with KeyBioscience
8 Jun 2017
Collaboration to focus on a potential new class of treatments for metabolic disorders.
Read more
FDA Advisory Committee to review Avastin biosimilar candidate
7 Jun 2017
The Committee will review analytical, pharmacokinetic and clinical data from studies involving ABP 215, including results from a Phase III study in patients with NSCLC.
Read more
New BMS collaboration to evaluate combination therapy in colorectal cancer
6 Jun 2017
Phase I/II study to evaluate the combination of Opdivo (nivolumab) and Opdivo +Yervoy (ipilimumab) regimen with Mekinist (trametinib) in patients with colorectal cancer.
Read more
Combination therapy shown to shrink tumours in many patients whose cancer has spread to the brain
5 Jun 2017
Combination of nivolumab plus ipilimumab can fundamentally change survival expectations.
Read more
Spinraza approved in the EU as first treatment for spinal muscular atrophy
2 Jun 2017
Robust data from Phase III studies demonstrated positive impact on motor milestone achievement; increased survival in infants with SMA.
Read more
NICE approves first use of Opdivo in blood cancer
2 Jun 2017
NICE has recommended immunotherapy drug nivolumab for the treatment of adult patients with classical Hodgkin lymphoma.
Read more